XM tidak memberikan layanan kepada penduduk Amerika Serikat.

What is Marburg virus, and how worrying is it?



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>EXPLAINER-What is Marburg virus, and how worrying is it?</title></head><body>

By Jennifer Rigby

LONDON, Oct 3 (Reuters) -Rwanda is battling its first-ever outbreak of the deadly Marburg virus, with 36 cases reported so far and 11 deaths.

The World Health Organization said this week the risk of the outbreak is very high in Rwanda, high across the African region, and low globally.


What is Marburg virus?

Marburg is a virus from the same family as Ebola. It causes a haemorrhagic fever and has an average fatality rate of 50%, according to the WHO, although rates have been as high as 88% in previous outbreaks. Early clinical care and rehydration can improve survival, the U.N. health agency says.

Symptoms typically include a sudden high fever and extreme headache, as well as vomiting and diarrhea, following by uncontrolled bleeding.

It was first identified in Marburg, Germany - hence the name - and Belgrade, Serbia in 1967, after laboratory work with African green monkeys from Uganda led to human infections. Since then, there have been outbreaks and sporadic cases in Angola, the Democratic Republic of the Congo, Kenya, South Africa and Uganda, the WHO says.


How does it spread?

Marburg spreads to humans from prolonged exposure to mines or caves where Rousettus fruit bats live. It can also spread between humans, through direct contact with the bodily fluids of infected people, or with surfaces or materials contaminated with those fluids, such as blood.


Is there a vaccine?

There are no approved vaccines or treatments for Marburg, but there are a number of promising candidates that could begin trials soon, Rwanda's health minister has said. These include vaccine candidates developed by non-profit organizations including the Sabin Vaccine Institute, which has said it is working with Rwandan officials on the outbreak, as well as the International AIDS Vaccine Initiative (IAVI).

The team that developed the AstraZeneca COVID-19 vaccine at Oxford University began a trial of its Marburg candidate this summer in the UK, using similar technology.

What else is happening?

Rwanda is also monitoring around 300 contacts of known cases. Around 70% of confirmed cases are healthcare workers from two health facilities in the capital, Kigali, although cases have been reported from seven of the country's 30 districts. As well as spreading in healthcare facilities, the disease can also spread at funerals for those killed by the disease, which involve close physical contact with the deceased in some cultures as they are prepared for burial, said Paul Hunter, a professor of medicine at the University of East Anglia.

Health authorities around the world are on the alert for any spread to neighbouring countries or beyond.


Is Marburg reaching new places, and why?

Yes - in 2021, Guinea reported West Africa's first ever case of Marburg. In 2022, Ghana declared its first ever outbreak, and Tanzania and Equatorial Guinea did the same in 2023. These generally small outbreaks were brought under control with public health measures. Scientists have said the increased frequency of the outbreaks seem to be linked to human encroachment on animal habitats.

The Rwanda outbreak is already one of the biggest ever.



Reporting by Jennifer Rigby; Editing by Chizu Nomiyama

</body></html>

Pengungkapan: Entitas XM Group menyediakan layanan khusus eksekusi dan akses ke Fasilitas Trading Online kami, yang memungkinkan Anda untuk melihat dan/atau menggunakan konten yang tersedia pada atau melalui situs, yang tidak untuk mengubah atau memperluas, serta tidak mengubah atau memperluas hal tersebut. Akses dan penggunaan ini selalu sesuai dengan: (i) Syarat dan Ketentuan; (ii) Peringatan Risiko; dan (iii) Pengungkapan Penuh. Oleh karena itu, konten disediakan hanya sebagai informasi umum. Anda juga harus ketahui bahwa konten Fasilitas Trading Online kami bukan sebagai ajakan atau tawaran untuk untuk melakukan transaksi apa pun di pasar finansial. Trading di pasar finansial mana pun melibatkan tingkat risiko yang signifikan pada modal Anda.

Semua materi yang diterbitkan di Fasilitas Trading Online kami hanya untuk tujuan edukasi/informasi dan tidak boleh mengandung nasihat dan rekomendasi finansial, pajak investasi atau trading, catatan harga trading kami, penawaran, permintaan, transaksi dalam instrumen finansial apa pun atau promo finansial untuk Anda yang tidak diminta.

Konten pihak ketiga apa pun, serta konten yang disiapkan oleh XM, seperti opini, berita, riset, analisis, harga, informasi lain atau link ke situs pihak ketiga yang tersedia "sebagaimana adanya", sebagai komentar pasar umum dan bukan menjadi nasihat investasi. Sejauh konten apa pun ditafsirkan sebagai penelitian investasi, Anda harus memperhatikan dan menerima bahwa konten tersebut tidak dimaksudkan dan belum disiapkan sesuai dengan persyaratan hukum yang dirancang untuk mempromosikan kemandirian riset investasi dan dengan demikian akan dianggap sebagai komunikasi pemasaran di bawah hukum dan peraturan yang relevan. Mohon dipastikan bahwa Anda telah membaca dan memahami Notifikasi pada Riset Investasi Non-Independen dan Peringatan Risiko kami mengenai informasi di atas, yang dapat diakses disini.

Peringatan Resiko: Modal Anda beresiko. Produk dengan leverage mungkin tidak cocok bagi semua orang. Silahkan pertimbangkan Pengungkapan Resiko kami.